JPH08175943A - Composition for oral cavity - Google Patents
Composition for oral cavityInfo
- Publication number
- JPH08175943A JPH08175943A JP6335883A JP33588394A JPH08175943A JP H08175943 A JPH08175943 A JP H08175943A JP 6335883 A JP6335883 A JP 6335883A JP 33588394 A JP33588394 A JP 33588394A JP H08175943 A JPH08175943 A JP H08175943A
- Authority
- JP
- Japan
- Prior art keywords
- potassium nitrate
- composition
- sodium
- oral cavity
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 210000000214 mouth Anatomy 0.000 title claims abstract 8
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Chemical compound [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 claims abstract description 58
- 235000010333 potassium nitrate Nutrition 0.000 claims abstract description 29
- 239000004323 potassium nitrate Substances 0.000 claims abstract description 29
- 235000001014 amino acid Nutrition 0.000 claims abstract description 16
- 150000001413 amino acids Chemical class 0.000 claims abstract description 15
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 13
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 13
- 150000003839 salts Chemical class 0.000 claims abstract description 13
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 12
- AUHDWARTFSKSAC-HEIFUQTGSA-N (2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-(6-oxo-1H-purin-9-yl)oxolane-2-carboxylic acid Chemical compound [C@]1([C@H](O)[C@H](O)[C@@H](CO)O1)(N1C=NC=2C(O)=NC=NC12)C(=O)O AUHDWARTFSKSAC-HEIFUQTGSA-N 0.000 claims abstract description 4
- GRSZFWQUAKGDAV-UHFFFAOYSA-N Inosinic acid Natural products OC1C(O)C(COP(O)(O)=O)OC1N1C(NC=NC2=O)=C2N=C1 GRSZFWQUAKGDAV-UHFFFAOYSA-N 0.000 claims abstract description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims abstract description 4
- 235000013902 inosinic acid Nutrition 0.000 claims abstract description 4
- 239000004245 inosinic acid Substances 0.000 claims abstract description 4
- 229940028843 inosinic acid Drugs 0.000 claims abstract description 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims abstract description 4
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 claims description 5
- 229960000401 tranexamic acid Drugs 0.000 claims description 5
- 239000004475 Arginine Substances 0.000 claims description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 4
- 235000009697 arginine Nutrition 0.000 claims description 4
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 3
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 claims description 3
- 235000003704 aspartic acid Nutrition 0.000 claims description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 239000004220 glutamic acid Substances 0.000 claims description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 3
- 235000004554 glutamine Nutrition 0.000 claims description 3
- 235000008729 phenylalanine Nutrition 0.000 claims description 3
- 235000019658 bitter taste Nutrition 0.000 abstract description 18
- 229940034610 toothpaste Drugs 0.000 abstract description 18
- 239000000606 toothpaste Substances 0.000 abstract description 18
- 208000035154 Hyperesthesia Diseases 0.000 abstract description 7
- 239000002324 mouth wash Substances 0.000 abstract description 6
- 229940051866 mouthwash Drugs 0.000 abstract description 6
- 230000001680 brushing effect Effects 0.000 abstract description 5
- 239000007788 liquid Substances 0.000 abstract description 4
- 239000004480 active ingredient Substances 0.000 abstract description 3
- 239000000551 dentifrice Substances 0.000 abstract 2
- 238000005406 washing Methods 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 24
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 16
- 239000008213 purified water Substances 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 229940024606 amino acid Drugs 0.000 description 11
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 9
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 9
- 235000011187 glycerol Nutrition 0.000 description 8
- 239000002304 perfume Substances 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 7
- -1 temperature Substances 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 5
- 239000001768 carboxy methyl cellulose Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 5
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 4
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000013923 monosodium glutamate Nutrition 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 229940073490 sodium glutamate Drugs 0.000 description 4
- 229960003500 triclosan Drugs 0.000 description 4
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000009610 hypersensitivity Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 229940085605 saccharin sodium Drugs 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- 210000005239 tubule Anatomy 0.000 description 3
- 108010001682 Dextranase Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 2
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- AANLCWYVVNBGEE-IDIVVRGQSA-L Disodium inosinate Chemical compound [Na+].[Na+].O[C@@H]1[C@H](O)[C@@H](COP([O-])([O-])=O)O[C@H]1N1C(NC=NC2=O)=C2N=C1 AANLCWYVVNBGEE-IDIVVRGQSA-L 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- FENRSEGZMITUEF-ATTCVCFYSA-E [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] Chemical compound [Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].OP(=O)([O-])O[C@@H]1[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H](OP(=O)([O-])[O-])[C@H](OP(=O)(O)[O-])[C@H]1OP(=O)([O-])[O-] FENRSEGZMITUEF-ATTCVCFYSA-E 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 235000013890 disodium inosinate Nutrition 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000004088 foaming agent Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 1
- 235000013928 guanylic acid Nutrition 0.000 description 1
- 239000004226 guanylic acid Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229950005425 sodium myristyl sulfate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229940083982 sodium phytate Drugs 0.000 description 1
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、知覚過敏予防用の有効
成分として配合された硝酸カリウム由来の苦味が低減さ
れて使用感に優れ、知覚過敏予防用として好適に使用し
得る口腔用組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an oral composition which has a reduced bitterness derived from potassium nitrate, which is incorporated as an active ingredient for the prevention of hyperesthesia, and has an excellent feeling in use, and which can be preferably used for the prevention of hyperesthesia. .
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】知覚過
敏とは、歯のエナメル質又はセメント質が消失して象牙
質が露出し、この象牙質に温度的、化学的、機械的など
の外来刺激が与えられることによって、一時的に不快な
痛みを感じるものである。これは象牙細管を通じて神経
が刺激されるためと考えられており、予防策としては象
牙細管を封鎖させるか、あるいは神経を鈍麻させるとい
ったアプローチがなされている。具体的には、象牙細管
を封鎖させるものとして特開昭61−36212号公報
に記載の方法、神経を鈍麻させるものとして米国特許第
3863006号に記載の方法などがある。2. Description of the Related Art Hypersensitivity means the loss of enamel or cementum in the tooth to expose dentin, which is a foreign material such as temperature, chemical or mechanical. When the stimulus is given, it causes temporary uncomfortable pain. It is thought that this is because nerves are stimulated through the dentinal tubules, and as a preventive measure, an approach such as blocking the dentinal tubules or blunting the nerves is taken. Specifically, there is a method described in JP-A-61-36212 for blocking dentinal tubules, and a method described in US Pat. No. 3,863,006 for blunting nerves.
【0003】一方、知覚過敏の予防策として、神経鈍麻
作用を持ち、知覚過敏予防の有効成分として公知である
硝酸カリウムを口腔用組成物に配合することが知られて
いる。On the other hand, as a preventive measure against hyperesthesia, it is known to incorporate potassium nitrate, which has a blunting effect on nerves and is known as an active ingredient for preventing hyperesthesia, into an oral composition.
【0004】しかしながら、硝酸カリウムは、薬剤の苦
味が強く、実使用上非常に不快感を伴うという欠点があ
る上、このように強い不快感を伴うと、自然に歯磨や洗
口の時間が短くなり、口腔衛生上好ましくないという欠
点もあり、従って、硝酸カリウム由来の苦味の改善が望
まれる。[0004] However, potassium nitrate has a drawback that the bitterness of the drug is strong and it is very uncomfortable in actual use. In addition, such strong discomfort naturally shortens the time for tooth brushing and mouthwash. However, there is also a drawback that it is not preferable from the viewpoint of oral hygiene, and therefore improvement in bitterness derived from potassium nitrate is desired.
【0005】本発明は、上記事情に鑑みなされたもの
で、硝酸カリウム由来の苦味が軽減され、使用感に優れ
た硝酸カリウム含有の口腔用組成物を提供することを目
的とする。The present invention has been made in view of the above circumstances, and an object thereof is to provide a potassium nitrate-containing oral composition having a reduced bitterness derived from potassium nitrate and an excellent feeling in use.
【0006】[0006]
【課題を解決するための手段及び作用】本発明者は、上
記目的を達成するため鋭意検討を重ねた結果、硝酸カリ
ウムを含有してなる口腔用組成物に、アミノ酸及びその
塩並びに核酸及びその塩を配合することにより、硝酸カ
リウム由来の苦味が軽減され、実使用上不快感を伴うこ
とがなく、歯磨や洗口を十分な時間をとって自然に行う
ことができ、口腔衛生上非常に好ましく知覚過敏防止用
として好適に使用できる口腔用組成物が得られることを
知見し、本発明をなすに至ったものである。Means and Actions for Solving the Problems As a result of intensive studies to achieve the above object, the present inventor has found that an oral composition containing potassium nitrate contains an amino acid and a salt thereof, and a nucleic acid and a salt thereof. By blending, the bitterness derived from potassium nitrate is reduced, there is no discomfort in actual use, tooth brushing and mouth rinsing can be performed naturally for a sufficient time, and it is very preferable for oral hygiene. The present invention has been completed by finding that an oral composition that can be suitably used for preventing hypersensitivity can be obtained.
【0007】以下、本発明につき更に詳述すると、本発
明の口腔用組成物は、練歯磨、液状歯磨等の歯磨類、マ
ウスウオッシュ、洗口剤等として調整され、硝酸カリウ
ムにアミノ酸及びその塩並びに核酸及びその塩から選ば
れるものを併用したものである。The present invention will be described in more detail below. The oral composition of the present invention is prepared as toothpaste, toothpaste such as liquid toothpaste, mouthwash, mouthwash, etc., and amino acid and its salt in potassium nitrate and It is a combination of nucleic acids and salts thereof.
【0008】ここで、硝酸カリウムの配合量は組成物全
体の0.005重量%以上20重量%以下、特に0.1
重量%以上7重量%以下が好ましく、20重量%を超え
ると苦味が強すぎてアミノ酸や核酸類を配合しても満足
に改善し得ない場合がある。The content of potassium nitrate in the composition is 0.005% by weight or more and 20% by weight or less, particularly 0.1% by weight or less.
The amount is preferably not less than 7% by weight and more than 20% by weight, and if it exceeds 20% by weight, the bitterness may be too strong to improve satisfactorily even if amino acids and nucleic acids are added.
【0009】次に、アミノ酸としては、例えばグリシ
ン,アラニン,リジン,ロイシン,イソロイシン,フェ
ニルアラニン,チロシン,スレオニン,セリン,プロリ
ン,ヒドロキシプロリン,トリプトファン,アスパラギ
ン酸,グルタミン酸,アスパラギン,グルタミン,アル
ギニン,トラネキサム酸等が挙げられ、これらの中では
フェニルアラニン,アルギニン,アスパラギン酸,グル
タミン,グルタミン酸,トラネキサム酸が好適に用いら
れる。また、アミノ酸の塩としては、これらアミノ酸の
ナトリウム、カリウム等のアルカリ金属塩が好ましく用
いられる。Next, as amino acids, for example, glycine, alanine, lysine, leucine, isoleucine, phenylalanine, tyrosine, threonine, serine, proline, hydroxyproline, tryptophan, aspartic acid, glutamic acid, asparagine, glutamine, arginine, tranexamic acid, etc. Among these, phenylalanine, arginine, aspartic acid, glutamine, glutamic acid, and tranexamic acid are preferably used. As the amino acid salt, alkali metal salts such as sodium and potassium of these amino acids are preferably used.
【0010】また、核酸としては、例えばイノシン酸、
アデニル酸、グアニル酸等が挙げられ、特にイノシン酸
が好ましい。核酸の塩としては、これら核酸のナトリウ
ム、カリウム等のアルカリ金属塩が好ましく用いられ
る。The nucleic acid is, for example, inosinic acid,
Examples thereof include adenylic acid and guanylic acid, and inosinic acid is particularly preferable. As the nucleic acid salt, alkali metal salts such as sodium and potassium of these nucleic acids are preferably used.
【0011】本発明では、上記したアミノ酸及びその塩
並びに核酸及びその塩から選ばれる1種又は2種以上を
配合するが、その配合量は、組成物全体の0.001〜
10重量%、特に0.005〜2重量%が望ましい。配
合量が0.001重量%に満たないと満足な苦味改善効
果が得られない場合があり、10重量%を超えると歯磨
の発泡性が低下する等の現象が現れることがあり、また
アミノ酸や核酸自体の味が強くなり嗜好的にも好ましく
なくなる場合がある。In the present invention, one kind or two or more kinds selected from the above-mentioned amino acids and salts thereof and nucleic acids and salts thereof are blended, and the blending amount thereof is 0.001 to
10% by weight, particularly 0.005 to 2% by weight is desirable. If the blending amount is less than 0.001% by weight, a satisfactory bitterness improving effect may not be obtained, and if it exceeds 10% by weight, phenomena such as a decrease in foamability of toothpaste may occur, and amino acids and In some cases, the taste of the nucleic acid itself becomes strong and the taste becomes unfavorable.
【0012】本発明の口腔用組成物には、上記必須成分
以外に剤型に応じたその他の任意成分を配合することが
できる。具体的には、各種研磨剤、粘結剤、粘稠剤、発
泡剤、香料、甘味剤、防腐剤等や、デキストラナーゼ、
溶菌酵素等の酵素、クロルヘキシジン、トリクロサン、
塩化セチルピリジニウム等の種々の殺菌剤、乳酸アルミ
ニウム、塩化ナトリウム、フッ化物、生薬エキス等が挙
げられる。なお、これら任意成分の配合量は、本発明の
効果を妨げない範囲で通常量とすることができる。In addition to the above-mentioned essential components, the oral composition of the present invention may contain other optional components depending on the dosage form. Specifically, various abrasives, binders, thickeners, foaming agents, flavors, sweeteners, preservatives, etc., dextranase,
Enzymes such as lytic enzymes, chlorhexidine, triclosan,
Various fungicides such as cetylpyridinium chloride, aluminum lactate, sodium chloride, fluorides, crude drug extracts and the like can be mentioned. In addition, the compounding amount of these optional components can be a usual amount within a range that does not impair the effects of the present invention.
【0013】[0013]
【発明の効果】本発明の口腔用組成物は、硝酸カリウム
由来の苦味が軽減され、使用上の不快感が伴わず、歯磨
や洗口の時間が短縮されるようなこともないものので、
知覚過敏防止用として口腔衛生上好ましく使用すること
ができる。The oral composition of the present invention reduces the bitterness derived from potassium nitrate, does not cause discomfort during use, and does not shorten the time for tooth brushing or mouthwashing.
It can be preferably used from the viewpoint of oral hygiene for preventing hypersensitivity.
【0014】[0014]
【実施例】以下、実験例及び実施例を挙げて本発明を具
体的に説明するが、本発明は下記実施例に制限されるも
のではない。The present invention will be specifically described below with reference to experimental examples and examples, but the present invention is not limited to the following examples.
【0015】〔実験例〕表1に示す組成の練歯磨に0.
5%となるように各種アミノ酸又は核酸を加え、無配合
のものと苦味を比較した。配合したアミノ酸及び配合歯
磨の苦味を表2に示す。苦味は下記方法により評価し
た。 苦味の評価方法:歯磨を約1g歯ブラシにとり、90秒
間歯磨きを行った。歯磨きの際の苦味を官能的に評価
し、下記の基準により評点した。 評価基準 ×:非常に苦い △:苦味がやや軽減 ○:苦味が非常に軽減 表1の結果、アミノ酸や核酸を加えることによって硝酸
カリウム由来の苦味が緩和され、苦痛なく歯を磨けるこ
とがわかった。[Experimental Example] A toothpaste having the composition shown in Table 1 has a density of 0.
Various amino acids or nucleic acids were added so that the concentration would be 5%, and the bitterness was compared with that of a non-blended product. Table 2 shows the bitterness of the blended amino acids and the blended toothpaste. The bitterness was evaluated by the following method. Evaluation method of bitterness: About 1 g of toothpaste was placed on a toothbrush and brushed for 90 seconds. The bitterness at the time of tooth brushing was sensory evaluated and evaluated according to the following criteria. Evaluation criteria x: Very bitter Δ: Slightly reduced bitterness ◯: Very reduced bitterness As a result of Table 1, it was found that the addition of amino acids and nucleic acids alleviated the bitterness derived from potassium nitrate and brushed teeth without pain.
【0016】[0016]
【表1】 [Table 1]
【0017】[0017]
【表2】 [Table 2]
【0018】 〔実施例1〕練歯磨 第2リン酸カルシウム 47.0% 無水ケイ酸 2.5 ソルビット液 24.0 プロピレングリコール 3.0 カルボキシメチルセルロースナトリウム 1.0 アルギン酸ナトリウム 0.2 ラウリル硫酸ナトリウム 1.5 サッカリンナトリウム 1.0 パラオキシ安息香酸エチル 0.1 香料 1.0 硝酸カリウム 5.0 グルタミン酸ナトリウム 0.005精製水 残 計 100.0%Example 1 Toothpaste Dicalcium Phosphate 47.0% Silicic Acid Anhydrous 2.5 Solbit Solution 24.0 Propylene Glycol 3.0 Sodium Carboxymethyl Cellulose 1.0 Sodium Alginate 0.2 Sodium Lauryl Sulfate 1.5 Saccharin sodium 1.0 Ethyl paraoxybenzoate 0.1 Perfume 1.0 Potassium nitrate 5.0 Sodium glutamate 0.005 Purified water Residual 100.0%
【0019】 〔実施例2〕練歯磨 水酸化アルミニウム 50.0% グリセリン 8.0 ソルビット液 15.0 プロピレングリコール 2.0 カルボキシメチルセルロースナトリウム 1.0 アルギン酸ナトリウム 0.2 ラウリル硫酸ナトリウム 1.8 サッカリンナトリウム 0.2 パラオキシ安息香酸エチル 0.2 香料 1.0 硝酸カリウム 5.0 アラニン 0.03精製水 残 計 100.0%Example 2 Toothpaste Aluminum hydroxide 50.0% Glycerin 8.0 Solbit solution 15.0 Propylene glycol 2.0 Sodium carboxymethylcellulose 1.0 Sodium alginate 0.2 Sodium lauryl sulfate 1.8 Sodium saccharin 0 .2 Ethyl paraoxybenzoate 0.2 Perfume 1.0 Potassium nitrate 5.0 Alanine 0.03 Purified water Residual 100.0%
【0020】 〔実施例3〕練歯磨 中性化処理水酸化アルミニウム 42.0% 無水ケイ酸 2.5 ソルビット液 23.0 カラギーナン 0.5 ミリスチル硫酸ナトリウム 1.3 アルギン酸ナトリウム 0.5 2−アルキル−N−カルボキシメチル−N−ヒドロ 0.3 キシエチルイミダゾリンベタイン サッカリンナトリウム 0.1 パラオキシ安息香酸エチル 0.05 デキストラナーゼ 17.5(u/g) 塩酸クロルヘキシジン 0.01 モノフルオロリン酸ナトリウム 0.75 香料 1.0 硝酸カリウム 5.0 アルギニン 1.0精製水 残 計 100.0%Example 3 Toothpaste Neutralization Treatment Aluminum hydroxide 42.0% Silicic anhydride 2.5 Sorbit solution 23.0 Carrageenan 0.5 Sodium myristyl sulfate 1.3 Sodium alginate 0.5 2-Alkyl -N-carboxymethyl-N-hydro 0.3 xyethyl imidazoline betaine saccharin sodium 0.1 ethyl paraoxybenzoate 0.05 dextranase 17.5 (u / g) chlorhexidine hydrochloride 0.01 sodium monofluorophosphate 0. 75 Fragrance 1.0 Potassium nitrate 5.0 Arginine 1.0 Purified water Residual total 100.0%
【0021】 〔実施例4〕練歯磨 グリセリン 20.0% 無水ケイ酸 20.0 ソルビット液 40.0 プロピレングリコール 2.5 カルボキシメチルセルロースナトリウム 1.0 ゼラチン 0.3 N−ラウロイルタウレート 1.2 サッカリンナトリウム 1.0 フィチン酸5ナトリウム 0.8 香料 1.0 硝酸カリウム 3.3 トリクロサン 0.4 トラネキサム酸ナトリウム 0.7精製水 残 計 100.0%[Example 4] Toothpaste Glycerin 20.0% Silicic anhydride 20.0 Sorbit solution 40.0 Propylene glycol 2.5 Sodium carboxymethyl cellulose 1.0 Gelatin 0.3 N-Lauroyl taurate 1.2 Sodium saccharin 1.0 Sodium phytate 0.8 Perfume 1.0 Potassium nitrate 3.3 Triclosan 0.4 Sodium tranexamate 0.7 Purified water Residual 100.0%
【0022】 〔実施例5〕練歯磨 ジルコノシリケート 25.0% 無水ケイ酸 2.0 ソルビット液 40.0 ポリエチレングリコール400 5.0 ポリアクリル酸ナトリウム 1.0 ラウリル硫酸ナトリウム 1.0 サッカリンナトリウム 0.1 香料 1.1 パラオキシ安息香酸メチル 0.1 パラオキシ安息香酸ブチル 0.1 グルコン酸クロルヘキシジン 0.05 硝酸カリウム 1.0 トリプトファン 0.005精製水 残 計 100.0%[Example 5] Toothpaste Zirconosilicate 25.0% Silicic anhydride 2.0 Solbit solution 40.0 Polyethylene glycol 400 5.0 Sodium polyacrylate 1.0 Sodium lauryl sulfate 1.0 Sodium saccharin 0. 1 Perfume 1.1 Methyl paraoxybenzoate 0.1 Butyl paraoxybenzoate 0.1 Chlorhexidine gluconate 0.05 Potassium nitrate 1.0 Tryptophan 0.005 Purified water Residual 100.0%
【0023】 〔実施例6〕練歯磨 無水ケイ酸 20.0% ソルビット液 22.0 プロピレングリコール 3.5 α−オレフィンスルホン酸ナトリウム 1.8 サッカリンナトリウム 1.0 パラオキシ安息香酸メチル 0.1 香料 1.0 アラントイン 0.05 ゼオライト 0.1 フッ化ナトリウム 0.02 トリクロサン 0.3 硝酸カリウム 5.0 トラネキサム酸 1.0精製水 残 計 100.0%Example 6 Toothpaste Silicic anhydride 20.0% Sorbit solution 22.0 Propylene glycol 3.5 Sodium α-olefin sulfonate 1.8 Saccharin sodium 1.0 Methyl paraoxybenzoate 0.1 Perfume 1. 0 Allantoin 0.05 Zeolite 0.1 Sodium fluoride 0.02 Triclosan 0.3 Potassium nitrate 5.0 Tranexamic acid 1.0 Purified water Residual 100.0%
【0024】 〔実施例7〕練歯磨 炭酸カルシウム 40.0% プロピレングリコール 3.0 グリセリン 20.0 カルボキシメチルセルロースナトリウム 1.5 酸化チタン 0.5 ラウリル硫酸ナトリウム 0.2 サッカリンナトリウム 0.1 パラオキシ安息香酸エチル 0.1 香料 1.0 塩化セチルピリジニウム 0.8 グルタミン酸ナトリウム 0.1精製水 残 計 100.0%[Example 7] Toothpaste Calcium carbonate 40.0% Propylene glycol 3.0 Glycerin 20.0 Sodium carboxymethyl cellulose 1.5 Titanium oxide 0.5 Sodium lauryl sulfate 0.2 Sodium saccharin 0.1 Ethyl paraoxybenzoate 0.1 Fragrance 1.0 Cetylpyridinium chloride 0.8 Sodium glutamate 0.1 Purified water Residual 100.0%
【0025】 〔実施例8〕練歯磨 炭酸カルシウム 40.0% プロピレングリコール 3.0 グリセリン 20.0 カルボキシメチルセルロースナトリウム 1.5 酸化チタン 0.2 ラウリル硫酸ナトリウム 2.5 サッカリンナトリウム 1.0 パラオキシ安息香酸エチル 0.1 香料 1.0 塩化ナトリウム 1.0 硝酸カリウム 5.0 グルタミン酸ナトリウム 0.005精製水 残 計 100.0%[Example 8] Toothpaste Calcium carbonate 40.0% Propylene glycol 3.0 Glycerin 20.0 Sodium carboxymethylcellulose 1.5 Titanium oxide 0.2 Sodium lauryl sulfate 2.5 Sodium saccharin 1.0 Ethyl paraoxybenzoate 0.1 Fragrance 1.0 Sodium chloride 1.0 Potassium nitrate 5.0 Sodium glutamate 0.005 Purified water Residual amount 100.0%
【0026】 〔実施例9〕練歯磨 沈降性シリカ 20.0% 増粘性シリカ 3.0 ソルビット液 35.0 プロピレングリコール 2.0 グリセリン 10.0 二酸化チタン 0.5 カラギーナン 1.0 ガントレッツ 1.0 ラウリル硫酸ナトリウム 1.5 サッカリンナトリウム 1.0 パラオキシ安息香酸エチル 0.1 香料 1.0 硝酸カリウム 5.0 グルタミン酸ナトリウム 0.02精製水 残 計 100.0%[Example 9] Toothpaste Precipitating silica 20.0% Thickening silica 3.0 Solbit liquid 35.0 Propylene glycol 2.0 Glycerin 10.0 Titanium dioxide 0.5 Carrageenan 1.0 Gantrez 1.0 Sodium lauryl sulfate 1.5 Sodium saccharin 1.0 Ethyl paraoxybenzoate 0.1 Perfume 1.0 Potassium nitrate 5.0 Sodium glutamate 0.02 Purified water Residual total 100.0%
【0027】 〔実施例10〕液状歯磨 グリセリン 35.0% プロピレングリコール 5.0 ポリアクリル酸ナトリウム 0.5 無水ケイ酸 15.0 ラウリル硫酸ナトリウム 1.0 サッカリンナトリウム 0.3 安息香酸ナトリウム 0.3 トリクロサン 0.1 β−グリチルレチン酸 0.05 香料 4.0 硝酸カリウム 3.0 トラネキサム酸 0.1精製水 残 計 100.0%[Example 10] Liquid toothpaste Glycerin 35.0% Propylene glycol 5.0 Sodium polyacrylate 0.5 Silicic anhydride 15.0 Sodium lauryl sulfate 1.0 Sodium saccharin 0.3 Sodium benzoate 0.3 Triclosan 0.1 β-glycyrrhetinic acid 0.05 Fragrance 4.0 Potassium nitrate 3.0 Tranexamic acid 0.1 Purified water Residual amount 100.0%
【0028】 〔実施例11〕マウスウオッシュ グリセリン 15.0% エタノール 15.0 ポリオキシエチレン硬化ヒマシ油 1.0 サッカリンナトリウム 0.01 安息香酸ナトリウム 0.3 香料 4.0 色素 0.004 モノグリセリド硫酸ナトリウム 0.3 リン酸2ナトリウム 0.05 硝酸カリウム 1.0 イノシン酸ナトリウム 1.0精製水 残 計 100.0%[Example 11] Mouthwash Glycerin 15.0% Ethanol 15.0 Polyoxyethylene hydrogenated castor oil 1.0 Sodium saccharin 0.01 Sodium benzoate 0.3 Perfume 4.0 Dye 0.004 Sodium monoglyceride sulfate 0 .3 Disodium phosphate 0.05 Potassium nitrate 1.0 Sodium inosinate 1.0 Purified water Residual 100.0%
【0029】 〔実施例12〕洗口剤 エタノール 50.0% グリセリン 30.0 ポリオキシエチレン硬化ヒマシ油 1.0 サッカリンナトリウム 0.3 色素 0.0002 香料 3.0 塩化リゾチーム 0.3 硝酸カリウム 5.0 リジン 0.5精製水 残 計 100.0%Example 12 Mouthwash Ethanol 50.0% Glycerin 30.0 Polyoxyethylene hydrogenated castor oil 1.0 Sodium saccharin 0.3 Pigment 0.0002 Perfume 3.0 Lysozyme chloride 0.3 Potassium nitrate 5.0 Lysine 0.5 Purified water Residual 100.0%
Claims (2)
びに核酸及びその塩から選ばれる1種又は2種以上とを
併用してなることを特徴とする口腔用組成物。1. An oral composition comprising a combination of potassium nitrate and one or more selected from amino acids and salts thereof and nucleic acids and salts thereof.
塩として、フェニルアラニン、アルギニン、アスパラギ
ン酸、グルタミン、グルタミン酸、トラネキサム酸、イ
ノシン酸及びそれらの水溶性塩の1種又は2種以上を配
合した請求項1記載の口腔用組成物。2. A mixture of one or more of phenylalanine, arginine, aspartic acid, glutamine, glutamic acid, tranexamic acid, inosinic acid and their water-soluble salts as amino acids and salts thereof and nucleic acids and salts thereof. The composition for oral cavity according to 1.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33588394A JP3389719B2 (en) | 1994-12-22 | 1994-12-22 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP33588394A JP3389719B2 (en) | 1994-12-22 | 1994-12-22 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH08175943A true JPH08175943A (en) | 1996-07-09 |
JP3389719B2 JP3389719B2 (en) | 2003-03-24 |
Family
ID=18293448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP33588394A Expired - Fee Related JP3389719B2 (en) | 1994-12-22 | 1994-12-22 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3389719B2 (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998005342A1 (en) * | 1996-08-06 | 1998-02-12 | Taisho Pharmaceutical Co., Ltd. | Liquid preparation comprising iron compound |
GB2354441A (en) * | 1999-08-06 | 2001-03-28 | Mccormack Ltd | Composition for treating dentine hypersensitivity |
JP2003521486A (en) * | 2000-01-31 | 2003-07-15 | ウルトラデント・プロダクツ・インコーポレーテッド | Compositions and methods for whitening teeth and reducing sensitivity |
JP2007254315A (en) * | 2006-03-22 | 2007-10-04 | Koki Kobayashi | Rock salt-containing sanitary composition for oral cavity |
JP2009173564A (en) * | 2008-01-23 | 2009-08-06 | Yamasa Shoyu Co Ltd | Salivation promotor |
JP2011511066A (en) * | 2008-02-08 | 2011-04-07 | コルゲート・パーモリブ・カンパニー | Oral care products and methods of use and manufacture thereof |
JP2011511068A (en) * | 2008-02-08 | 2011-04-07 | コルゲート・パーモリブ・カンパニー | Oral care products and methods of use and manufacture thereof |
JP2011511796A (en) * | 2008-02-08 | 2011-04-14 | コルゲート・パーモリブ・カンパニー | Dental wipe |
JP2012522801A (en) * | 2009-04-01 | 2012-09-27 | コルゲート・パーモリブ・カンパニー | Oral composition for treating dental hypersensitivity and method for using and manufacturing the same |
WO2014038195A1 (en) | 2012-09-05 | 2014-03-13 | 株式会社サンギ | Oral composition |
KR20140072055A (en) | 2011-09-28 | 2014-06-12 | 라이온 가부시키가이샤 | Oral composition |
US8936778B2 (en) | 1998-11-12 | 2015-01-20 | Ultradent Products, Inc. | Methods for bleaching and desensitizing teeth |
JP2015083556A (en) * | 2013-10-25 | 2015-04-30 | ライオン株式会社 | Dentifrice composition |
JP2017141178A (en) * | 2016-02-09 | 2017-08-17 | ライオン株式会社 | Dentifrice composition |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61155314A (en) * | 1984-12-28 | 1986-07-15 | Lion Corp | Composition for oral purpose |
JPS63171909A (en) * | 1987-01-07 | 1988-07-15 | Dorein Kogyo Kk | River embankment work |
JPS63233909A (en) * | 1987-02-12 | 1988-09-29 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Dentifrice composition for removing pain for pain-sensitive tooth |
JPH04247024A (en) * | 1991-02-04 | 1992-09-03 | Kanebo Ltd | Vitamin b-containing oral liquid agent |
JPH05931A (en) * | 1991-06-25 | 1993-01-08 | Lion Corp | Composition for oral cavity |
JPH054921A (en) * | 1990-11-19 | 1993-01-14 | Kanebo Ltd | Vitamin b-containing oral solution agent |
JPH05124963A (en) * | 1991-11-06 | 1993-05-21 | Showa Yakuhin Kako Kk | Theophylline-containing liquid agent |
JPH06105625A (en) * | 1992-09-29 | 1994-04-19 | Shikoku Sogo Kenkyusho:Kk | Method for water-culturing vegetable |
-
1994
- 1994-12-22 JP JP33588394A patent/JP3389719B2/en not_active Expired - Fee Related
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS61155314A (en) * | 1984-12-28 | 1986-07-15 | Lion Corp | Composition for oral purpose |
JPS63171909A (en) * | 1987-01-07 | 1988-07-15 | Dorein Kogyo Kk | River embankment work |
JPS63233909A (en) * | 1987-02-12 | 1988-09-29 | ユニリーバー・ナームローゼ・ベンノートシヤープ | Dentifrice composition for removing pain for pain-sensitive tooth |
JPH054921A (en) * | 1990-11-19 | 1993-01-14 | Kanebo Ltd | Vitamin b-containing oral solution agent |
JPH04247024A (en) * | 1991-02-04 | 1992-09-03 | Kanebo Ltd | Vitamin b-containing oral liquid agent |
JPH05931A (en) * | 1991-06-25 | 1993-01-08 | Lion Corp | Composition for oral cavity |
JPH05124963A (en) * | 1991-11-06 | 1993-05-21 | Showa Yakuhin Kako Kk | Theophylline-containing liquid agent |
JPH06105625A (en) * | 1992-09-29 | 1994-04-19 | Shikoku Sogo Kenkyusho:Kk | Method for water-culturing vegetable |
Cited By (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998005342A1 (en) * | 1996-08-06 | 1998-02-12 | Taisho Pharmaceutical Co., Ltd. | Liquid preparation comprising iron compound |
US8936778B2 (en) | 1998-11-12 | 2015-01-20 | Ultradent Products, Inc. | Methods for bleaching and desensitizing teeth |
GB2354441A (en) * | 1999-08-06 | 2001-03-28 | Mccormack Ltd | Composition for treating dentine hypersensitivity |
JP2003521486A (en) * | 2000-01-31 | 2003-07-15 | ウルトラデント・プロダクツ・インコーポレーテッド | Compositions and methods for whitening teeth and reducing sensitivity |
JP2007254315A (en) * | 2006-03-22 | 2007-10-04 | Koki Kobayashi | Rock salt-containing sanitary composition for oral cavity |
JP2009173564A (en) * | 2008-01-23 | 2009-08-06 | Yamasa Shoyu Co Ltd | Salivation promotor |
JP2011511068A (en) * | 2008-02-08 | 2011-04-07 | コルゲート・パーモリブ・カンパニー | Oral care products and methods of use and manufacture thereof |
JP2011511796A (en) * | 2008-02-08 | 2011-04-14 | コルゲート・パーモリブ・カンパニー | Dental wipe |
JP2011511066A (en) * | 2008-02-08 | 2011-04-07 | コルゲート・パーモリブ・カンパニー | Oral care products and methods of use and manufacture thereof |
US9682027B2 (en) | 2008-02-08 | 2017-06-20 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
JP2012522801A (en) * | 2009-04-01 | 2012-09-27 | コルゲート・パーモリブ・カンパニー | Oral composition for treating dental hypersensitivity and method for using and manufacturing the same |
KR20180102685A (en) | 2011-09-28 | 2018-09-17 | 라이온 가부시키가이샤 | Oral composition |
KR20140072055A (en) | 2011-09-28 | 2014-06-12 | 라이온 가부시키가이샤 | Oral composition |
KR20180102686A (en) | 2011-09-28 | 2018-09-17 | 라이온 가부시키가이샤 | Oral composition |
KR20180102204A (en) | 2011-09-28 | 2018-09-14 | 라이온 가부시키가이샤 | Oral composition |
KR20180102205A (en) | 2011-09-28 | 2018-09-14 | 라이온 가부시키가이샤 | Oral composition |
KR20150034270A (en) | 2012-09-05 | 2015-04-02 | 가부시키가이샤 상기 | Oral composition |
US9468593B2 (en) | 2012-09-05 | 2016-10-18 | Kabushiki Kaisha Sangi | Oral composition |
WO2014038195A1 (en) | 2012-09-05 | 2014-03-13 | 株式会社サンギ | Oral composition |
CN105658194A (en) * | 2013-10-25 | 2016-06-08 | 狮王株式会社 | Tooth paste composition |
WO2015060426A1 (en) * | 2013-10-25 | 2015-04-30 | ライオン株式会社 | Tooth paste composition |
JP2015083556A (en) * | 2013-10-25 | 2015-04-30 | ライオン株式会社 | Dentifrice composition |
CN105658194B (en) * | 2013-10-25 | 2019-03-29 | 狮王株式会社 | Dentrifice composition |
JP2017141178A (en) * | 2016-02-09 | 2017-08-17 | ライオン株式会社 | Dentifrice composition |
Also Published As
Publication number | Publication date |
---|---|
JP3389719B2 (en) | 2003-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA3009833C (en) | Oral care compositions and methods of using the compositions | |
RU2628540C2 (en) | Oral care products, including zinc oxide and trimethylglycine | |
CA3047921C (en) | Oral care compositions | |
JP3389719B2 (en) | Oral composition | |
US20250228754A1 (en) | Oral Care Compositions | |
US10980720B2 (en) | Oral care compositions | |
WO2003003994A1 (en) | Oral preparation | |
AU2017379612B2 (en) | Oral care compositions | |
JPH10501265A (en) | Mouth rinse composition | |
JP4109727B2 (en) | Composition for oral cavity containing amino acid surfactant | |
JP2009107988A (en) | Dentifrice composition | |
JP6610208B2 (en) | Oral composition | |
JP3987593B2 (en) | Oral composition containing sodium chloride and magnesium chloride | |
JP3803868B2 (en) | Oral composition | |
CA3149613A1 (en) | Zinc phosphate containing compositions | |
JPH09241140A (en) | Composition for oral cavity | |
JP2013112655A (en) | Dentifrice composition | |
JPH10245328A (en) | Powdery dentifrice composition | |
JPWO2018043717A1 (en) | Oral composition | |
JPH07285838A (en) | Composition for oral cavity application | |
JPH08301743A (en) | Dentifrice composition | |
JP2004018521A (en) | Formulation for oral cavity | |
JP2004059563A (en) | Oral cavity composition for dentinal hyperesthesia | |
JP2005179230A (en) | Dentifrice composition | |
JPH0558865A (en) | Toothpaste composition and its production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090117 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090117 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100117 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100117 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110117 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120117 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120117 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130117 Year of fee payment: 10 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140117 Year of fee payment: 11 |
|
LAPS | Cancellation because of no payment of annual fees |